At the moment, Fresenius Kabi and Biogen seem to be well ahead of their rivals in the category, which include Celltrion and Gedeon Richter. The German drugmaker said the Tyenne approval – its ...
This milestone comes just a few months after the NOC approval of Tyenne ® (tocilizumab) and Idacio ® (adalimumab) Citrate-free formulation. Fresenius Kabi, an operating company of Fresenius ...
With this approval, Fresenius Kabi Canada's immunology biosimilar portfolio is further expanding, offering more treatment options for patients with chronic autoimmune conditions Otulfi TM is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback